Project Details
| Short title | 1397-0012 |
|---|---|
| Acronym | 1397-0012 |
| Status | Active |
| Effective start/end date | 22/06/22 → 25/05/27 |
CTU: A randomised, double-blind, placebo-controlled, parallel group, dose-finding study evaluating efficacy, safety and tolerability of BI 1291583 qd over at least 24 weeks in patients with bronchiectasis
- Morgan, Lucy (Primary Chief Investigator)
- Chapman, Nicola (Clinical Trial Unit Staff)
- Chester, Catherine (Clinical Trial Unit Staff)
Project: Research